Caselmann WH - Search Results

1

Efficient gene transfer into lymphoma cells using adenoviral vectors combined with lipofection.

Buttgereit P, Weineck S, Röpke G, Märten A, Brand K, Heinicke T, Caselmann WH, Huhn D, Schmidt-Wolf IG. Buttgereit P, et al. Among authors: caselmann wh. Cancer Gene Ther. 2000 Aug;7(8):1145-55. doi: 10.1038/sj.cgt.7700209. Cancer Gene Ther. 2000. PMID: 10975675

2

Increased VEGF levels induced by anti-VEGF treatment are independent of tumor burden in colorectal carcinomas in mice.

Schmitz V, Vilanueva H, Raskopf E, Hilbert T, Barajas M, Dzienisowicz C, Gorschlüter M, Strehl J, Rabe C, Sauerbruch T, Prieto J, Caselmann WH, Qian C. Schmitz V, et al. Among authors: caselmann wh. Gene Ther. 2006 Aug;13(16):1198-205. doi: 10.1038/sj.gt.3302772. Epub 2006 Apr 13. Gene Ther. 2006. PMID: 16617302

3

Treatment of metastatic colorectal carcinomas by systemic inhibition of vascular endothelial growth factor signaling in mice.

Schmitz V, Kornek M, Hilbert T, Dzienisowicz C, Raskopf E, Rabe C, Sauerbruch T, Qian C, Caselmann WH. Schmitz V, et al. Among authors: caselmann wh. World J Gastroenterol. 2005 Jul 28;11(28):4332-6. doi: 10.3748/wjg.v11.i28.4332. World J Gastroenterol. 2005. PMID: 16038030 Free PMC article.

4

Synthetic antisense oligodeoxynucleotides as potential drugs against hepatitis C.

Caselmann WH, Eisenhardt S, Alt M. Caselmann WH, et al. Intervirology. 1997;40(5-6):394-9. doi: 10.1159/000150571. Intervirology. 1997. PMID: 9675643 Review.

5

Comparative inhibitory potential of differently modified antisense oligodeoxynucleotides on hepatitis C virus translation.

Alt M, Eisenhardt S, Serwe M, Renz R, Engels JW, Caselmann WH. Alt M, et al. Among authors: caselmann wh. Eur J Clin Invest. 1999 Oct;29(10):868-76. doi: 10.1046/j.1365-2362.1999.00552.x. Eur J Clin Invest. 1999. PMID: 10583429

6

Interaction of Hepatitis B virus with cellular processes in liver carcinogenesis.

Rabe C, Caselmann WH. Rabe C, et al. Among authors: caselmann wh. Crit Rev Clin Lab Sci. 2000 Oct;37(5):407-29. doi: 10.1080/10408360091174277. Crit Rev Clin Lab Sci. 2000. PMID: 11078055 Review.

7

Carcinogenesis of primary liver malignancies.

Dürr R, Caselmann WH. Dürr R, et al. Among authors: caselmann wh. Langenbecks Arch Surg. 2000 Apr;385(3):154-61. doi: 10.1007/s004230050259. Langenbecks Arch Surg. 2000. PMID: 10857485 Review.

8

Transactivation of cellular gene expression by hepatitis B viral proteins: a possible molecular mechanism of hepatocarcinogenesis.

Caselmann WH. Caselmann WH. J Hepatol. 1995;22(1 Suppl):34-7. J Hepatol. 1995. PMID: 7602073 Review.

9

[Guidelines of the German Society of Digestive and Metabolic Diseases for diagnosis and therapy of hepatocellular carcinoma. German Society of Digestive and Metabolic Diseases].

Caselmann WH, Blum HE, Fleig WE, Huppert PE, Ramadori G, Schirmacher P, Sauerbruch T. Caselmann WH, et al. Z Gastroenterol. 1999 May;37(5):353-65. Z Gastroenterol. 1999. PMID: 10413843 German. No abstract available.

10

Molecular mechanisms of hepatitis B virus-associated liver cancer.

Rabe C, Cheng B, Caselmann WH. Rabe C, et al. Among authors: caselmann wh. Dig Dis. 2001;19(4):279-87. doi: 10.1159/000050694. Dig Dis. 2001. PMID: 11935087 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

94 results

Search Page

Filters